TD Ameritrade Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,952
| Closed | -$228K | – | 176 |
|
|
2023
Q2 | $228K | Sell |
2,952
-561
| -16% | -$43.3K | ﹤0.01% | 159 |
|
|
2023
Q1 | $291K | Sell |
3,513
-703
| -17% | -$58.2K | ﹤0.01% | 150 |
|
|
2022
Q4 | $362K | Sell |
4,216
-1,101
| -21% | -$94.5K | ﹤0.01% | 154 |
|
|
2022
Q3 | $328K | Sell |
5,317
-1,137
| -18% | -$70.1K | ﹤0.01% | 167 |
|
|
2022
Q2 | $399K | Sell |
6,454
-5,261
| -45% | -$325K | ﹤0.01% | 180 |
|
|
2022
Q1 | $696K | Buy |
11,715
+571
| +5% | +$33.9K | 0.01% | 158 |
|
|
2021
Q4 | $809K | Buy |
11,144
+3,551
| +47% | +$258K | 0.01% | 141 |
|
|
2021
Q3 | $480K | Buy |
7,593
+4,470
| +143% | +$283K | ﹤0.01% | 158 |
|
|
2021
Q2 | $215K | Buy |
3,123
+482
| +18% | +$33.2K | ﹤0.01% | 231 |
|
|
2021
Q1 | $154K | Hold |
2,641
| – | – | ﹤0.01% | 235 |
|
|
2020
Q4 | $154K | Sell |
2,641
-4,952
| -65% | -$289K | ﹤0.01% | 235 |
|
|
2020
Q3 | $480K | Sell |
7,593
-497
| -6% | -$31.4K | ﹤0.01% | 158 |
|
|
2020
Q2 | $622K | Sell |
8,090
-930
| -10% | -$71.5K | 0.01% | 145 |
|
|
2020
Q1 | $674K | Buy |
9,020
+80
| +0.9% | +$5.98K | 0.01% | 140 |
|
|
2019
Q4 | $581K | Buy |
8,940
+1,636
| +22% | +$106K | ﹤0.01% | 161 |
|
|
2019
Q3 | $463K | Buy |
7,304
+2,030
| +38% | +$129K | ﹤0.01% | 164 |
|
|
2019
Q2 | $356K | Buy |
5,274
+1,332
| +34% | +$89.9K | ﹤0.01% | 166 |
|
|
2019
Q1 | $256K | Buy |
3,942
+933
| +31% | +$60.6K | ﹤0.01% | 173 |
|
|
2018
Q4 | $188K | Buy |
3,009
+2,029
| +207% | +$127K | ﹤0.01% | 161 |
|
|
2018
Q3 | $76K | Buy |
+980
| New | +$76K | ﹤0.01% | 192 |
|